AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 283: E275-E283, 2002. First published April 2, 2002; doi:10.1152/ajpendo.00424.2001
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
283/2/E275    most recent
00424.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singhal, P.
Right arrow Articles by Taylor, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singhal, P.
Right arrow Articles by Taylor, R.
Vol. 283, Issue 2, E275-E283, August 2002

Regulation of endogenous glucose production after a mixed meal in type 2 diabetes

Parag Singhal1, Andrea Caumo2, Peter E. Carey1, Claudio Cobelli2, and Roy Taylor1

1 Diabetes Research Group, School of Clinical Medical Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4HH, United Kingdom; and 2 Dept of Electronics and Informatics, University of Padova, Padua I35131, Italy

The extent and time course of suppression of endogenous glucose production (EGP) in type 2 diabetes after a mixed meal have been determined using a new tracer methodology. Groups of age-, sex-, and weight-matched normal controls (n = 8) and diet-controlled type 2 diabetic subjects (n = 8) were studied after ingesting a standard mixed meal (550 kcal; 67% carbohydrate, 19% fat, 14% protein). There was an early insulin increment in both groups such that, by 20 min, plasma insulin levels were 266 ± 54 and 190 ± 53 pmol/l, respectively. EGP was similar basally [2.55 ± 0.12 mg · kg-1 · min-1 in control subjects vs. 2.92 ± 0.16 mg · kg-1 · min-1 in the patients (P = 0.09)]. After glucose ingestion, EGP declined rapidly in both groups to ~50% of basal within 30 min of the meal. Despite the initial rapid decrease, the EGP was significantly greater in the diabetic group at 60 min (1.75 ± 0.12 vs. 1.05 ± 0.14 mg · kg-1 · min-1; P < 0.01) and did not reach nadir until 210 min (0.96 ± 0.17 mg · kg-1 · min-1). Between 60 and 240 min, EGP was 47% higher in the diabetic group (0.89 ± 0.09 vs. 1.31 ± 0.13 mg · kg-1 · min-1, P < 0.02). These data quantitate the initial rapid suppression of EGP after a mixed meal in type 2 diabetes and the contribution of continuing excess glucose production to subsequent hyperglycemia.

liver; insulin sensitivity


This article has been cited by other articles:


Home page
 J. Pharmacol. Exp. Ther.Home page
W. Gu, H. Yan, K. A. Winters, R. Komorowski, S. Vonderfecht, L. Atangan, G. Sivits, D. Hill, J. Yang, V. Bi, et al.
Long-Term Inhibition of the Glucagon Receptor with a Monoclonal Antibody in Mice Causes Sustained Improvement in Glycemic Control, with Reversible {alpha}-Cell Hyperplasia and Hyperglucagonemia
J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 871 - 881.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
A. Basu, C. Dalla Man, R. Basu, G. Toffolo, C. Cobelli, and R. A. Rizza
Effects of Type 2 Diabetes on Insulin Secretion, Insulin Action, Glucose Effectiveness, and Postprandial Glucose Metabolism
Diabetes Care, May 1, 2009; 32(5): 866 - 872.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. Yan, W. Gu, J. Yang, V. Bi, Y. Shen, E. Lee, K. A. Winters, R. Komorowski, C. Zhang, J. J. Patel, et al.
Fully Human Monoclonal Antibodies Antagonizing the Glucagon Receptor Improve Glucose Homeostasis in Mice and Monkeys
J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 102 - 111.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
M. E. Pennant, L. J.C. Bluck, M. L. Marcovecchio, B. Salgin, R. Hovorka, and D. B. Dunger
Insulin Administration and Rate of Glucose Appearance in People With Type 1 Diabetes
Diabetes Care, November 1, 2008; 31(11): 2183 - 2187.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Visinoni, B. C. Fam, A. Blair, C. Rantzau, B. J. Lamont, R. Bouwman, M. J. Watt, J. Proietto, J. M. Favaloro, and S. Andrikopoulos
Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1132 - E1141.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
B. Ravikumar, J. Gerrard, C. Dalla Man, M. J. Firbank, A. Lane, P. T. English, C. Cobelli, and R. Taylor
Pioglitazone Decreases Fasting and Postprandial Endogenous Glucose Production in Proportion to Decrease in Hepatic Triglyceride Content
Diabetes, September 1, 2008; 57(9): 2288 - 2295.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. Bock, C. Dalla Man, M. Campioni, E. Chittilapilly, R. Basu, G. Toffolo, C. Cobelli, and R. Rizza
Pathogenesis of Pre-Diabetes: Mechanisms of Fasting and Postprandial Hyperglycemia in People With Impaired Fasting Glucose and/or Impaired Glucose Tolerance
Diabetes, December 1, 2006; 55(12): 3536 - 3549.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. D. van Poelje, S. C. Potter, V. C. Chandramouli, B. R. Landau, Q. Dang, and M. D. Erion
Inhibition of Fructose 1,6-Bisphosphatase Reduces Excessive Endogenous Glucose Production and Attenuates Hyperglycemia in Zucker Diabetic Fatty Rats
Diabetes, June 1, 2006; 55(6): 1747 - 1754.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. J. Woerle, E. Szoke, C. Meyer, J. M. Dostou, S. D. Wittlin, N. R. Gosmanov, S. L. Welle, and J. E. Gerich
Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes
Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E67 - E77.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
B. Ravikumar, P. E. Carey, J. E. M. Snaar, D. K. Deelchand, D. B. Cook, R. D. G. Neely, P. T. English, M. J. Firbank, P. G. Morris, and R. Taylor
Real-time assessment of postprandial fat storage in liver and skeletal muscle in health and type 2 diabetes
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E789 - E797.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Krssak, A. Brehm, E. Bernroider, C. Anderwald, P. Nowotny, C. D. Man, C. Cobelli, G. W. Cline, G. I. Shulman, W. Waldhausl, et al.
Alterations in Postprandial Hepatic Glycogen Metabolism in Type 2 Diabetes
Diabetes, December 1, 2004; 53(12): 3048 - 3056.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
K. B. Degn, C. B. Juhl, J. Sturis, G. Jakobsen, B. Brock, V. Chandramouli, J. Rungby, B. R. Landau, and O. Schmitz
One Week's Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and {alpha}- and {beta}-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes
Diabetes, May 1, 2004; 53(5): 1187 - 1194.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. C. Moore, S. Satake, M. Lautz, S. A. Soleimanpour, D. W. Neal, M. Smith, and A. D. Cherrington
Nonesterified Fatty Acids and Hepatic Glucose Metabolism in the Conscious Dog
Diabetes, January 1, 2004; 53(1): 32 - 40.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Vella, A. S. Reed, N. Charkoudian, P. Shah, R. Basu, A. Basu, M. J. Joyner, and R. A. Rizza
Glucose-induced suppression of endogenous glucose production: dynamic response to differing glucose profiles
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E25 - E30.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
P. E. Carey, J. Halliday, J. E. M. Snaar, P. G. Morris, and R. Taylor
Direct assessment of muscle glycogen storage after mixed meals in normal and type 2 diabetic subjects
Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E688 - E694.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online